RxDoctor Payments Data

Kristi Leindecker, MD

Family Medicine · Dover, OHNPI 1457347619

Payments from drug & device makers

$664in general payments, 2019–2025

Across 42 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$139
  • AbbVie$119
  • Pfizer$77
  • Astellas Pharma US Inc$38
  • Boehringer Ingelheim$31
  • Amgen$29
  • plus $231 from 13 others

What the payments were for

  • Food & beverage$63495%
  • Education$305%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$664 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$32,958
Medicare patients
205
Services billed
747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$63,986
EliquisApixaban61$45,862
XareltoRivaroxaban66$39,746
JardianceEmpagliflozin31$29,771
TrulicityDulaglutide16$15,152
MounjaroTirzepatide11$11,035
Repatha SureclickEvolocumab12$6,455
LinzessLinaclotide11$5,833
Atorvastatin Calcium360$3,706
Metoprolol Succinate268$3,457
SymbicortBudesonide/Formoterol Fumarate13$2,818
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$2,648
Valsartan82$2,583
Levothyroxine Sodium309$2,555
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$2,218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$63,98650 claims
PfizerEliquis$77$45,86261 claims
Johnson & JohnsonXarelto$15$39,74666 claims
Boehringer IngelheimJardiance$31$29,77131 claims
Lilly USA, LLCTrulicity, Mounjaro$139$26,18627 claims
AbbVieLinzess, Synthroid$119$7,66057 claims
AstraZenecaSymbicort$13$2,81813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Dover

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →